Live & Upcoming Events
Create an account
ESC Premium Access
How to facilitate the management and improve outcomes in patients after a cardiovascular event, is the cardiovascular polypill the answer?
ESC CONGRESS 2016
Primary cardiovascular prevention: interventions and outcomes
Sponsored by Ferrer
28 August 2016
18:30 - 19:30
in this session
How to identify very high cardiovascular risk patients and their therapeutic approach.
Professor D. Grobbee (Utrecht, NL)
The relationship between adherence to medication and cardiovascular outcomes: MINERVA study.
Doctor J. Castellano Vazquez (Madrid, ES)
New therapeutic strategy in secondary prevention: The Societies consensus on polypill management.
Professor J. Gonzalez Juanatey (Santiago de Compostela, ES)
The Cardiovascular Polypill, an opportunity for a new therapeutic approach.
Doctor V. Fuster (New York, US)
from this session
Professor Diederick E Grobbee
University Medical Center Utrecht, Utrecht (Netherlands (The))
Doctor Jose Maria Castellano Vazquez
Spanish National Centre for Cardiovascular Research, Madrid (Spain)
Professor Jose Ramon Gonzalez Juanatey
University Hospital of Santiago de Compostela, Santiago de Compostela (Spain)
Doctor Valentin Fuster
Mount Sinai Health System, New York (United States of America)
This platform is supported by